Many breast cancer patients are risking their lives by failing to take the tamoxifen they are prescribed, University of Dundee research suggests. The British Journal of Cancer study found 50% of women failed to finish the five year course of the drug needed to maximise their survival chances.
Link to Article
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment